UK markets open in 4 hours 28 minutes
  • NIKKEI 225

    +37.62 (+0.13%)

    -72.08 (-0.36%)

    -0.17 (-0.19%)

    -0.50 (-0.03%)
  • DOW

    +76.67 (+0.23%)

    +153.80 (+0.80%)
  • CMC Crypto 200

    +5.77 (+1.08%)
  • ^IXIC

    -63.04 (-0.50%)
  • ^FTAS

    -6.81 (-0.17%)

EssilorLuxottica : Final results of EssilorLuxottica’s public offer for GrandVision shares

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
·6-min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

Final results of EssilorLuxottica’s public offer
for GrandVision shares

  • Following the Post-Acceptance Period that ended on December 20, the Offeror will hold in total approximately 99.84% of the issued share capital of GrandVision

  • Settlement of the Shares tendered during the Post-Acceptance Period will take place on 23 December 2021

  • The last trading date of the Shares on Euronext Amsterdam will be on 7 January 2022 and listing and trading of the Shares will terminate as of 10 January 2022

  • The Offeror will initiate statutory buy-out proceedings in order to obtain 100% of the Shares

Charenton-le-Pont, France and Schiphol, the Netherlands (21 December 2021 – 7:00am CET) – EssilorLuxottica S.A. (the “Offeror”) and GrandVision N.V. (“GrandVision”) are pleased to announce the result of the post-acceptance period that ended on 20 December 2021 at 17:40 hours CET (the “Post-Acceptance Period”).

Terms not defined in this press release will have the meaning as set out in the Offeror’s offer memorandum dated 7 October 2021 (the “Offer Memorandum”).

During the Post-Acceptance Period, which expired at 17:40 hours CET on 20 December 2021, 268,744 Shares have been tendered under the Offer, representing an interest of approximately 0.11% of the issued share capital of GrandVision.

Including the 99.73% interest already held by the Offeror, the Offeror will hold a total of 254,031,577 Shares, representing approximately 99.84% of the issued share capital of GrandVision. This amounts to approximately 99.89% of the issued and outstanding shares in GrandVision.

With reference to the Offer Memorandum, Shareholders who accepted the Offer shall receive the Offer Price for each Share validly tendered (or defectively tendered provided that such defect has been waived by the Offeror) and delivered (geleverd) under the terms and restrictions of the Offer.

Settlement of the Offer shall occur and payment of the Offer Price per Share validly tendered (or defectively tendered provided that such defect has been waived by the Offeror) shall take place on 23 December 2021.

As announced on 13 December 2021, the listing and trading of the Shares on Euronext Amsterdam will be terminated, as a result of the Offeror holding more than 95% of the Shares.

In consultation with Euronext, it has been decided that delisting will take place on 10 January 2022 and the last trading day of the Shares will therefore be on 7 January 2022. Reference is made to Section 5.11.2 (Liquidity, delisting of the Shares and post-closing steps) of the Offer Memorandum.

Buy-out proceedings
As the Offeror has acquired more than 95% of the Shares, the Offeror intends to initiate, as soon as possible, the Buy-Out. Reference is made to Section 5.11.4 (Buy-out proceedings) of the Offer Memorandum.

Offer Memorandum, Position Statement and further information
This announcement contains selected, condensed information regarding the Offer and does not replace the Offer Memorandum and/or Position Statement. The information in this announcement is not complete and additional information is contained in the Offer Memorandum and Position Statement.

Digital copies of the Offer Memorandum are available on the website of the Offeror ( and digital copies of the Offer Memorandum and Position Statement are available on the website of GrandVision ( Such websites do not constitute part of, and are not incorporated by reference into, the Offer Memorandum.

Copies of the Offer Memorandum and the Position Statement are also available free of charge from GrandVision and the Exchange Agent.

GrandVision N.V.
The Base
Evert van de Beekstraat 1-80
Tower C, 6th floor
1118CL Schiphol
The Netherlands

Corporate Broking and Issuer Services HQ7212
Gustav Mahlerlaan 10
1082 PP Amsterdam
The Netherlands

About EssilorLuxottica
EssilorLuxottica is a global leader in the design, manufacture and distribution of ophthalmic lenses, frames and sunglasses. Formed in 2018, its mission is to help people around the world to see more, be more and live life to its fullest by addressing their evolving vision needs and personal style aspirations. The Company brings together the complementary expertise of two industry pioneers, one in advanced lens technology and the other in the craftsmanship of iconic eyewear, to set new industry standards for vision care and the consumer experience around it. Influential eyewear brands including Ray-Ban and Oakley, lens technology brands including Varilux and Transitions, and world-class retail brands including Sunglass Hut, LensCrafters and since 1st July (via a majority interest) - GrandVision are part of the EssilorLuxottica family. In 2020, EssilorLuxottica had over 140,000 employees and consolidated revenues of Euro 14.4 billion. The EssilorLuxottica share trades on the Euronext Paris market and is included in the Euro Stoxx 50 and CAC 40 indices. Codes and symbols: ISIN: FR0000121667; Reuters: ESLX.PA; Bloomberg: EL:FP. For more information, please visit

About GrandVision
GrandVision, part of the EssilorLuxottica group, is a global leader in optical retailing, delivering high quality and affordable eye care to more and more customers around the world. The high-quality eye care offered by GrandVision includes a wide range of services provided by its vision experts. Our products include prescription glasses including frames and lenses, contact lenses and contact lens care products, as well as sunglasses both plain and with prescription lenses. These products are offered through leading optical retail banners which operate in more than 40 countries across Europe, the Americas, the Middle East and Asia. GrandVision serves its customers in over 7,200 stores and with more than 39,000 employees, proving every day that in EYE CARE, WE CARE MORE. Since March 2021, GrandVision is a participant of the United Nations Global Compact and we adhere to our principle-based approach to responsible business. For more information, please visit


EssilorLuxottica GrandVision

Giorgio Iannella - Head of Investor Relations Annia Ballesteros – Investor Relations Director
e-mail: e-mail:

Marco Catalani - Head of Corporate Communications Carola Okhuijsen – Head of Corporate Communications
e-mail: e-mail:


This is a joint press release by EssilorLuxottica and GrandVision pursuant Section 17 paragraph 4 of the Dutch Decree on Public Takeover Bids (Besluit openbare biedingen Wft) in connection with the announced mandatory public offer by EssilorLuxottica for all the issued and outstanding shares in the share capital of GrandVision.

The Offer has been made for the ordinary shares of GrandVision, a Dutch company with shares listed on Euronext Amsterdam, and is subject to Dutch disclosure and procedural requirements, which may be different from those of the United States of America.

To the extent applicable, the Offer will be also conducted in the United States of America in accordance with the applicable provisions of Section 14(e) of the U.S. Securities Exchange Act of 1934 (the “Exchange Act”) and Regulation 14E adopted under the Exchange Act, and subject to any available exemptions provided by Rule 14d-1.

Neither the U.S. Securities and Exchange Commission nor any securities commission of any State of the United States of America has (a) approved or disapproved the Offer; (b) passed upon the merits or fairness of the Offer; or (c) passed upon the adequacy or accuracy of the disclosure in the offering document. Any representation to the contrary is a criminal offense in the United States of America.

The information in the press release is not intended to be complete. This announcement is for information purposes only and does not constitute an offer, or any solicitation of any offer, to buy or subscribe for any securities. Any offer is only made by means of the Offer Memorandum dated 7 October 2021 approved by the Netherlands Authority for the Financial Markets (Stichting Autoriteit Financiële Markten).

The distribution of this press release may, in some countries, be restricted by law or regulation. Accordingly, persons who come into possession of this document should inform themselves of and observe these restrictions. To the fullest extent permitted by applicable law, EssilorLuxottica and GrandVision disclaim any responsibility or liability for the violation of any such restrictions by any person. Any failure to comply with these restrictions may constitute a violation of the securities laws of that jurisdiction. Neither EssilorLuxottica, nor GrandVision, nor any of their advisors assumes any responsibility for any violation by any of these restrictions. Any GrandVision shareholder who is in any doubt as to his or her position should consult an appropriate professional advisor without delay.

This press release may contain forward-looking statements that reflect EssilorLuxottica’s and/or GrandVision’s current views with respect to future events and financial and operational performance. These forward-looking statements are based on EssilorLuxottica’s and/or GrandVision’s beliefs, assumptions and expectations regarding future events and trends that affect EssilorLuxottica’s and/or GrandVision’s future performance, taking into account all information currently available to EssilorLuxottica and/or GrandVision, and are not guarantees of future performance. By their nature, forward-looking statements involve risks and uncertainties because they relate to events and depend on circumstances that may or may not occur in the future, and EssilorLuxottica and GrandVision cannot guarantee the accuracy and completeness of forward-looking statements. A number of important factors, not all of which are known to EssilorLuxottica and/or GrandVision or are within EssilorLuxottica’s and/or GrandVision’s control, could cause actual results or outcomes to differ materially from those expressed in any forward-looking statement as a result of risks and uncertainties facing EssilorLuxottica and/or GrandVision. Any forward- looking statements are made only as of the date of this press release, and EssilorLuxottica and GrandVision assumes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information or for any other reason.


Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting